NADPH oxidases as potential pharmacological targets against increased seizure susceptibility after systemic inflammation.

Huang, Wan-Yu; Lin, Shankung; Chen, Hsuan-Ying; Chen, Ya-Ping; Chen, Ting-Yu; Hsu, Kuei-Sen; Wu, Hung-Ming

Huang, Wan-Yu; Lin, Shankung; Chen, Hsuan-Ying; Chen, Ya-Ping; Chen, Ting-Yu; Hsu, Kuei-Sen; Wu, Hung-Ming.

Affiliation

Huang WY; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lin S; Pediatrics of Kung-Ten General Hospital, Taichung City, Taiwan.
Chen HY; Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan.
Chen YP; Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan.
Chen TY; Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan.
Hsu KS; Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan.
Wu HM; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. richard@mail.ncku.edu.tw.

J Neuroinflammation ; 15(1): 140, 2018 May 12.

Article de En | MEDLINE | ID: mdl-29753328

Sujet(s)
Mots clés

Cytokine; Diphenyleneiodonium; Lipopolysaccharide; NADPH oxidase; Neuroninflammation; Seizure

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Crises épileptiques / Systèmes de délivrance de médicaments / Sepsie / NADPH oxidase Limites: Animals Langue: En Journal: J Neuroinflammation Sujet du journal: NEUROLOGIA Année: 2018 Type de document: Article Pays d'affiliation: Taïwan Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google